Evidence map›Paper›PMID 39393526›Full record

ArticleJournal of vascular surgery. Venous and lymphatic disorders2025

Protocol-based treatment of spontaneous hemorrhage from varicose veins prevents recurrence of bleeding.

Richard Bock, Danielle Fontenot, Spencer Bock, Gwyn Eiler, Kristie Worley-Fry, John Blebea

Abstract read
In one paragraph

Article in Journal of vascular surgery. Venous and lymphatic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Richard BockAsheville Vein Center, Asheville, NC. Electronic address: richard.bock@ashevilleveincenter.com.
Danielle FontenotAsheville Vein Center, Asheville, NC.
Spencer BockSchool of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Gwyn EilerAsheville Vein Center, Asheville, NC.
Kristie Worley-FryAsheville Vein Center, Asheville, NC.
John BlebeaDepartment of Surgery, Central Michigan University, Saginaw, MI.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSpontaneous hemorrhage from erosion of varicose veins through the skin is a serious and occasionally fatal complication of varicose vein disease. Various treatments, both acute and delayed, have been advocated. Our two-step clinical protocol was designed to prevent further hemorrhage without delay and to provide durable freedom from recurrent bleeding.

methodsAll patients referred to our surgical vein practice with hemorrhage from varicose veins were entered into a prospective registry. On presentation, all patients underwent diagnostic duplex ultrasound for venous reflux. Immediate treatment consisted of ultrasound-guided polidocanol/CO

resultsFifty-nine patients were referred with recent hemorrhage from varicose veins over a period of 4 years. Fifty-six (95%) had an ultrasound-identified tributary varicosity underlying the point of bleeding, and three had a skin-surface erosion only and no ultrasound-identified underlying tributary. Of the 59 study patients, 52 underwent prompt polidocanol/CO

conclusionsA two-step protocol of immediate ultrasound-guided foam sclerotherapy, followed within 8 weeks by endovenous ablation of incompetent axial veins and concurrent microphlebectomy, provided rapid and efficient treatment with durable freedom from subsequent hemorrhage.

Indexed as

HemorrhagePolidocanolRecurrenceSclerosing SolutionsSclerotherapyVaricose VeinsAdultAgedCarbon DioxideClinical ProtocolsFemaleHumansMaleMiddle AgedProspective StudiesRegistriesCarbon DioxidePolidocanolSclerosing SolutionsBleeding varicose veinsChronic venous insufficiencyFoam sclerotherapyVaricose vein complicationsVaricose vein hemorrhage

Identifiers

PMID39393526
PMCPMC11764482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.